Clinical Trial Update: Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet [Phase 1]

View source ↗

Summary

Phase 1 study comparing the safety and pharmacokinetics of CKD-390 tablets with Viread tablets in chronic hepatitis B; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• CKD-390
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED